| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.04 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |